No Data
No Data
Maxim Group Maintains MediWound(MDWD.US) With Buy Rating
Maxim Group analyst Michael Okunewitch maintains $MediWound(MDWD.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 29.0% and a total average return of -15.8% over
MediWound Price Target Maintained With a $28.00/Share by HC Wainwright & Co.
MediWound Price Target Maintained With a $28.00/Share by HC Wainwright & Co.
HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $28 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MediWound (NASDAQ:MDWD) with a Buy and maintains $28 price target.
MediWound Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/16/2024 34.94% HC Wainwright & Co. $28 → $28 Reiterates Buy → Buy 05/30/2024 34.94% HC Wainwright & Co.
MediWound Accelerates DFU Treatment With EIC Funds
Express News | MediWound Selected For €16.25M Funding From The European Innovation Council Accelerator Program
No Data